Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1633 1638
This examiner grants 73% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18096629 | ENGINEERED CARDIAC TISSUE STRUCTURES AND METHODS FOR FORMATION AND USE THEREOF | Non-Final OA | President and Fellows of Harvard College |
| 18566324 | Systems and Methods for Cellular Lumen Formation and Cellular Differentiation | Non-Final OA | The Regents of the University of California |
| 18462634 | Modular DNA Nanoshells for Cell Encapsulation and Ruggedization | Non-Final OA | Carnegie Mellon University |
| 17610671 | METHODS AND COMPOSITIONS FOR SELECTING TUMOR INFILTRATING LYMPHOCYTES AND USES OF THE SAME IN IMMUNOTHERAPY | Non-Final OA | Iovance Biotherapeutics, Inc. |
| 17794895 | ANAPLASTIC LYMPHOMA KINASE CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE | Non-Final OA | The Children's Medical Center Corporation |
| 18449657 | TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY MESENCHYMAL STEM CELL APOPTOTIC BODIES AND COMPOSITIONS THEREOF | Non-Final OA | Therapeutic Solutions International, Inc. |
| 18559381 | COMPOSITION FOR NK CELL CRYOPRESERVATION AND CRYOPRESERVATION FORMULATION COMPRISING SAME | Non-Final OA | GI CELL, INC. |
| 18551143 | GENE THERAPIES FOR 21-HYDROXYLASE DEFICIENCY | Non-Final OA | Adrenas Therapeutics, Inc. |
| 18548158 | EFFICIENT TRACELESS GENE EDITING SYSTEM FOR SALMONELLA AND USE THEREOF | Non-Final OA | JIANGSU TARGET BIOMEDICAL RESEARCH INSTITUTE CO., LTD. |
| 18033961 | MATURATION AGENT | Non-Final OA | Orizuru Therapeutics, Inc. |
| 18014072 | METHOD FOR PREPARING BISPECIFIC ANTIBODY USING ANNULAR ORBITALLY SHAKEN BIOREACTOR | Non-Final OA | CANTON BIOLOGICS CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy